CA3178892A1 - Synthesis of oligonucleotides and related compounds - Google Patents
Synthesis of oligonucleotides and related compoundsInfo
- Publication number
- CA3178892A1 CA3178892A1 CA3178892A CA3178892A CA3178892A1 CA 3178892 A1 CA3178892 A1 CA 3178892A1 CA 3178892 A CA3178892 A CA 3178892A CA 3178892 A CA3178892 A CA 3178892A CA 3178892 A1 CA3178892 A1 CA 3178892A1
- Authority
- CA
- Canada
- Prior art keywords
- compound
- nhbz
- optionally substituted
- group
- moiety
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/02—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with ribosyl as saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063003067P | 2020-03-31 | 2020-03-31 | |
| US63/003,067 | 2020-03-31 | ||
| PCT/IB2021/052595 WO2021198883A1 (en) | 2020-03-31 | 2021-03-30 | Synthesis of oligonucleotides and related compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3178892A1 true CA3178892A1 (en) | 2021-10-07 |
Family
ID=75340013
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3178892A Pending CA3178892A1 (en) | 2020-03-31 | 2021-03-30 | Synthesis of oligonucleotides and related compounds |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240092821A1 (https=) |
| EP (1) | EP4126894A1 (https=) |
| JP (1) | JP2023520201A (https=) |
| KR (1) | KR20220161436A (https=) |
| CN (1) | CN115843299A (https=) |
| AU (1) | AU2021247043A1 (https=) |
| BR (1) | BR112022019752A2 (https=) |
| CA (1) | CA3178892A1 (https=) |
| IL (1) | IL296862A (https=) |
| MX (1) | MX2022012255A (https=) |
| WO (1) | WO2021198883A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4293035A4 (en) | 2021-02-12 | 2025-03-05 | Ajinomoto Co., Inc. | METHOD FOR THE PRODUCTION OF OLIGONUCLEOTIDES |
| EP4601656A1 (en) * | 2022-10-12 | 2025-08-20 | Pharmorage Pty Limited | Modified oligonucleotides |
| WO2025028656A1 (ja) | 2023-08-02 | 2025-02-06 | 日東電工株式会社 | オリゴヌクレオチドを製造する方法 |
| WO2025235761A1 (en) * | 2024-05-09 | 2025-11-13 | Biogen Ma Inc. | Reagents and processes for preparing oligonucleotides |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992001704A1 (en) | 1990-07-26 | 1992-02-06 | Koichi Shudo | Oligodeoxyribonucleotides |
| US6972330B2 (en) * | 1996-02-13 | 2005-12-06 | Sirna Therapeutics, Inc. | Chemical synthesis of methoxy nucleosides |
| US5753789A (en) | 1996-07-26 | 1998-05-19 | Yale University | Oligonucleotides containing L-nucleosides |
| ES2192672T3 (es) | 1996-11-18 | 2003-10-16 | Takeshi Imanishi | Nuevos analogos de nucleotidos. |
| US6770748B2 (en) | 1997-03-07 | 2004-08-03 | Takeshi Imanishi | Bicyclonucleoside and oligonucleotide analogue |
| JP3756313B2 (ja) | 1997-03-07 | 2006-03-15 | 武 今西 | 新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体 |
| US6251666B1 (en) | 1997-03-31 | 2001-06-26 | Ribozyme Pharmaceuticals, Inc. | Nucleic acid catalysts comprising L-nucleotide analogs |
| US6794499B2 (en) | 1997-09-12 | 2004-09-21 | Exiqon A/S | Oligonucleotide analogues |
| JP4236812B2 (ja) | 1997-09-12 | 2009-03-11 | エクシコン エ／エス | オリゴヌクレオチド類似体 |
| ES2234563T5 (es) | 1999-02-12 | 2018-01-17 | Daiichi Sankyo Company, Limited | Nuevos análogos de nucleósidos y oligonucleótidos |
| JP2000247940A (ja) * | 1999-02-26 | 2000-09-12 | Sankyo Co Ltd | 新規ベンジルアジド化合物 |
| US7084125B2 (en) | 1999-03-18 | 2006-08-01 | Exiqon A/S | Xylo-LNA analogues |
| US7053207B2 (en) | 1999-05-04 | 2006-05-30 | Exiqon A/S | L-ribo-LNA analogues |
| US6525191B1 (en) | 1999-05-11 | 2003-02-25 | Kanda S. Ramasamy | Conformationally constrained L-nucleosides |
| JP4151751B2 (ja) | 1999-07-22 | 2008-09-17 | 第一三共株式会社 | 新規ビシクロヌクレオシド類縁体 |
| US7569575B2 (en) | 2002-05-08 | 2009-08-04 | Santaris Pharma A/S | Synthesis of locked nucleic acid derivatives |
| WO2004041889A2 (en) | 2002-11-05 | 2004-05-21 | Isis Pharmaceuticals, Inc. | Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| CN101684136A (zh) * | 2008-09-23 | 2010-03-31 | 苏州瑞博生物技术有限公司 | 一种寡核苷酸的制备方法 |
| US9284344B2 (en) | 2012-05-30 | 2016-03-15 | Hokkaido System Science Co., Ltd. | Oligonucleotide synthesis method using highly dispersible liquid-phase support |
| US10214555B2 (en) | 2012-11-14 | 2019-02-26 | Takeda Pharmaceutical Company Limitjed | Method for liquid-phase synthesis of nucleic acid |
| CN116063365A (zh) | 2015-12-16 | 2023-05-05 | 味之素株式会社 | 寡核苷酸的制备方法以及核苷、核苷酸或寡核苷酸 |
| WO2017111137A1 (ja) | 2015-12-22 | 2017-06-29 | 味の素株式会社 | オリゴヌクレオチドの製造方法 |
| TW201906855A (zh) | 2017-05-02 | 2019-02-16 | 日商日產化學工業股份有限公司 | 寡核苷酸之製造方法 |
-
2021
- 2021-03-30 US US17/916,064 patent/US20240092821A1/en active Pending
- 2021-03-30 AU AU2021247043A patent/AU2021247043A1/en not_active Abandoned
- 2021-03-30 CA CA3178892A patent/CA3178892A1/en active Pending
- 2021-03-30 CN CN202180039628.0A patent/CN115843299A/zh active Pending
- 2021-03-30 KR KR1020227037806A patent/KR20220161436A/ko active Pending
- 2021-03-30 EP EP21715980.5A patent/EP4126894A1/en active Pending
- 2021-03-30 JP JP2022559478A patent/JP2023520201A/ja active Pending
- 2021-03-30 WO PCT/IB2021/052595 patent/WO2021198883A1/en not_active Ceased
- 2021-03-30 MX MX2022012255A patent/MX2022012255A/es unknown
- 2021-03-30 BR BR112022019752A patent/BR112022019752A2/pt unknown
- 2021-03-30 IL IL296862A patent/IL296862A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN115843299A (zh) | 2023-03-24 |
| BR112022019752A2 (pt) | 2022-11-16 |
| IL296862A (en) | 2022-11-01 |
| WO2021198883A1 (en) | 2021-10-07 |
| KR20220161436A (ko) | 2022-12-06 |
| AU2021247043A1 (en) | 2022-10-27 |
| JP2023520201A (ja) | 2023-05-16 |
| US20240092821A1 (en) | 2024-03-21 |
| MX2022012255A (es) | 2023-01-11 |
| EP4126894A1 (en) | 2023-02-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA3178892A1 (en) | Synthesis of oligonucleotides and related compounds | |
| CA2744987C (en) | Method for the synthesis of phosphorus atom modified nucleic acids | |
| CA3134036A1 (en) | Technologies useful for oligonucleotide preparation | |
| EP4103577B1 (en) | Novel mrna 5'-end cap analogs, rna molecule incorporating the same, uses thereof and method of synthesizing rna molecule or peptide | |
| ES2376507T5 (es) | Análogos de ácidos nucleicos bicíclicos 6-disustituidos | |
| AU2008260277B2 (en) | N-substituted-aminomethylene bridged bicyclic nucleic acid analogs | |
| ES2439591T3 (es) | Análogos de ácido nucleico de tetrahidropirano | |
| KR20240141277A (ko) | 트리뉴클레오티드 캡 유사체 및 그의 사용 방법 | |
| BR112020020670A2 (pt) | composição de oligonucleotídeo, composição farmacêutica, método para alterar o splicing de uma transcrição alvo, método para tratar distrofia muscular, método para preparar um oligonucleotídeo ou uma composição de oligonucleotídeo do mesmo e oligonucleotídeo | |
| WO2018075827A1 (en) | Trinucleotide mrna cap analogs | |
| CA2936712A1 (en) | Chiral design | |
| CN110760516B (zh) | 核酸适配体衍生物和氨基化的核酸适配体衍生物以及它们的应用和药物偶合物 | |
| CN120129688A (zh) | 用于制备高度纯化的5′-加帽寡核苷酸的高效方法 | |
| RU2066325C1 (ru) | АНТИ-СЕНС ОЛИГОНУКЛЕОТИДНЫЕ ПОСЛЕДОВАТЕЛЬНОСТИ ПРОТИВ μРНК, ТНФ АЛЬФА | |
| WO2018156056A1 (ru) | Модифицированные олигонуклеотиды, активирующие рнказу н | |
| WO2025024563A2 (en) | Cap analogs and methods of use thereof | |
| KR20230074205A (ko) | 핵산 올리고머의 제조 방법 | |
| O'Flaherty et al. | Nonenzymatic RNA-templated synthesis of N3′→ P5′ phosphoramidate DNA | |
| Kumar et al. | Efficient synthesis of antisense phosphorothioate oligonucleotides using a universal solid support | |
| CN118974070A (zh) | 三核苷酸帽类似物及其使用方法 | |
| WO2022081046A1 (ru) | Химическое соединение с триазиновой группой и способ его получения | |
| RU2799452C2 (ru) | Химическое соединение с триазиновой группой и способ его получения | |
| CN121941694A (zh) | 帽类似物及其使用方法 | |
| WO2004048376A1 (ja) | 二環性ナフチリジンヌクレオシド | |
| BR112021018492B1 (pt) | Método para preparar um oligonucleotídeo e oligonucleotídeo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250915 |
|
| U13 | Renewal or maintenance fee not paid |
Free format text: ST27 STATUS EVENT CODE: N-1-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE Effective date: 20251117 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260202 |